Literature DB >> 11146241

Effect of antenatal betamethasone therapy on maternal-fetal Doppler velocimetry.

J J Piazze1, M M Anceschi, R La Torre, F Amici, L Maranghi, E V Cosmi.   

Abstract

BACKGROUND: The effect of antenatal betamethasone on fetal parameters includes a transient reduction of FHR variation and of fetal body movements. An effect on maternal-fetal blood flow has also been shown, with non-univocal results. AIMS: To evaluate the effect of antenatal betamethasone in third trimester singleton high-risk pregnancies by Doppler technology. SUBJECTS AND METHODS: Thirty-six pregnant women who received a full course of betamethasone (12 mg i.m. two times, 24 h apart) were studied. The Doppler examination included the assessment of the pulsatility index (PI) of the umbilical artery (UA PI), the middle cerebral artery (MCA PI) and of resistance index of uterine arteries (Ut RI) before treatment, and 48 and 96 h after second dose of betamethasone.
RESULTS: No significant variation was noted in UA PI through betamethasone therapy. MCA PI decreased significantly 48 h from the last injection of betamethasone (P=0.002), and returned to basal values at 96 h. No difference was found for the other Doppler parameters examined. When serial Doppler studies were analyzed according to the gestational age, in the group <32 weeks' gestation, MCA PI decreased significantly after 48 h (P<0.006) and returned to pre-treatment values after 96 h from the last betamethasone dose. Conversely, no difference was found in Doppler serial measurements in any of the analyzed districts in the subgroup > or =32 weeks.
CONCLUSION: Betamethasone treatment is associated with a significant, although transient, reduction of MCA PI, especially at gestational ages <32 weeks'.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11146241     DOI: 10.1016/s0378-3782(00)00120-1

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  5 in total

1.  Effect of maternal betamethasone administration on feto-placental vascular resistance in the mouse†.

Authors:  Lindsay S Cahill; Clare L Whitehead; Sebastian R Hobson; Greg Stortz; John C Kingdom; Ahmet Baschat; Kellie E Murphy; Lena Serghides; Christopher K Macgowan; John G Sled
Journal:  Biol Reprod       Date:  2019-10-25       Impact factor: 4.285

2.  Sex differences in modulation of fetoplacental vascular resistance in growth-restricted mouse fetuses following betamethasone administration: comparisons with human fetuses.

Authors:  Lindsay S Cahill; Shiri Shinar; Clare L Whitehead; Sebastian R Hobson; Greg Stortz; Viji Ayyathurai; Anjana Ravi Chandran; Anum Rahman; John C Kingdom; Ahmet Baschat; Kellie E Murphy; Lena Serghides; Christopher K Macgowan; John G Sled
Journal:  Am J Obstet Gynecol MFM       Date:  2020-10-06

3.  Comparing the effects of antenatal betamethasone on Doppler velocimetry between intrauterine growth restriction with and without preeclampsia.

Authors:  Kobra Shojaei; Nooshin Mohammadi
Journal:  Glob J Health Sci       Date:  2015-01-13

4.  The short term fetal cardiovascular effects of corticosteroids used in obstetrics.

Authors:  Amanda Henry; Antonia Shand; Alec Welsh
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

5.  Antenatal dexamethasone effect on Doppler blood flow velocity in women at risk for preterm birth: prospective case series.

Authors:  Elsnosy Elwany; Shaaban Omar; Abbas Ahmed; Gaber Heba; Darwish Atef
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.